Description
Matoxim-P contains Meloxicam 7.5mg + Paracetamol 325mg Tablet, a DCGI-approved pharmaceutical product for Pain & inflammation. Manufactured at Lxir Medilabs’ WHO-GMP certified facility and available for PCD Pharma Franchise across India with exclusive monopoly territory rights.
Key Uses
- Treatment and management of Pain & inflammation
- Prescribed by qualified healthcare professionals
- DCGI-approved, WHO-GMP certified formulation
- Available in standardised dosage for consistent therapeutic effect
Composition
Active Ingredient: Meloxicam 7.5mg + Paracetamol 325mg | Dosage Form: Tablet | Excipients q.s.
PCD Pharma Franchise for Matoxim-P
Matoxim-P (Meloxicam 7.5mg + Paracetamol 325mg) is available for PCD Pharma Franchise with exclusive monopoly rights across India. Lxir Medilabs offers this product as part of its comprehensive PCD franchise programme with full marketing and promotional support.
Why Choose Lxir Medilabs?
- Exclusive monopoly territory rights district-wise
- WHO-GMP & ISO certified manufacturing
- DCGI-approved product formulations
- Low investment starting from ₹25,000
- Free promotional material — visual aids, MR bags, samples
- Dedicated support team for franchise partners
Browse our full PCD Pharma Franchise product catalogue or call +91-98759-13317 to enquire about franchise availability in your state and district.
